NCT01832935View on ClinicalTrials.gov

Cost Effectiveness of Glargine Insulin Versus NPH Insulin

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

insulin glargine

The starting dose of insulin Glargine was 24 units per day (0.2-0.6 unit/kg) in 2 divided doses

DRUG

Insulin NPH

The starting dose of insulin NPH was 24 units per day (0.2-0.6 unit/kg) in 2 divided doses

Trial Locations (1)

13145-784

Tehran University of Medical Sciences, Tehran

All Listed Sponsors
lead

Tehran University of Medical Sciences

OTHER

NCT01832935 - Cost Effectiveness of Glargine Insulin Versus NPH Insulin | Biotech Hunter | Biotech Hunter